Literature DB >> 16182841

Peripheral extracorporeal membrane oxygenation (ECMO) in patients with posttransplant cardiac graft failure.

P Leprince1, S Aubert, N Bonnet, A Rama, Ph Léger, V Bors, J P Levasseur, J Szefner, E Vaissier, A Pavie, I Gandjbakhch.   

Abstract

INTRODUCTION: We sought to report the usefulness of extracorporeal membrane oxygenation (ECMO) in heart transplant patients. PATIENTS: Between March 2002 and August 2004, 14 heart transplant patients (11 men and three women, 36 +/- 15 years old, range = 12 to 50) with primary graft failure underwent peripheral ECMO implantation. Three patients had pulmonary hypertension and three had been transplanted with hearts from marginal donors. At the time of implantation, all were in severe cardiogenic shock despite maximal inotropic support. In six patients, the ECMO was implanted in the operating room since cardiopulmonary bypass could not be weaned. In the eight remaining patients, ECMO was implanted in the intensive care unit, during the first 48 hours in seven cases. In one patient, implantation was performed during external resuscitation. In all cases, femoral vessels were canulated using the Seldinger technique after anterior wall exposure. Distal arterial perfusion of the lower limb was systematically used.
RESULTS: Pump outflow was high enough in all the cases (mean: 2.6 +/- 0.2 L/min/m(2)). Three patients died on circulatory support. One patient was implanted with a total artificial heart after a few hours and another one underwent unsuccessful emergent retransplantation. Nine patients were weaned from ECMO after a mean duration of 5 +/- 2.5 days. Among them, one died of infection at 10 days after weaning and seven others were discharged to rehabilitation centers.
CONCLUSION: Fast operating room or bedside implantation of a peripheral ECMO allows the physician to stabilize the hemodynamic status of patients with cardiac graft failure, potentially leading toward myocardial recovery.

Entities:  

Mesh:

Year:  2005        PMID: 16182841     DOI: 10.1016/j.transproceed.2005.05.018

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  5 in total

1.  Extracorporeal life support following out-of-hospital refractory cardiac arrest.

Authors:  Morgan Le Guen; Armelle Nicolas-Robin; Serge Carreira; Mathieu Raux; Pascal Leprince; Bruno Riou; Olivier Langeron
Journal:  Crit Care       Date:  2011-01-18       Impact factor: 9.097

2.  Propofol, midazolam, vancomycin and cyclosporine therapeutic drug monitoring in extracorporeal membrane oxygenation circuits primed with whole human blood.

Authors:  Florian Lemaitre; Nesrine Hasni; Pascal Leprince; Emmanuel Corvol; Ghassen Belhabib; Pierre Fillâtre; Charles-Edouard Luyt; Cyril Leven; Robert Farinotti; Christine Fernandez; Alain Combes
Journal:  Crit Care       Date:  2015-02-12       Impact factor: 9.097

3.  Experts' recommendations for the management of adult patients with cardiogenic shock.

Authors:  Bruno Levy; Olivier Bastien; Bendjelid Karim; Karim Benjelid; Alain Cariou; Tahar Chouihed; Alain Combes; Alexandre Mebazaa; Bruno Megarbane; Patrick Plaisance; Alexandre Ouattara; Christian Spaulding; Christian Splaulding; Jean-Louis Teboul; Fabrice Vanhuyse; Thierry Boulain; Kaldoun Kuteifan
Journal:  Ann Intensive Care       Date:  2015-07-01       Impact factor: 6.925

4.  Primary Cardiac Allograft Dysfunction-Validation of a Clinical Definition.

Authors:  Vamsidhar B Dronavalli; Chris A Rogers; Nicholas R Banner
Journal:  Transplantation       Date:  2015-09       Impact factor: 4.939

5.  Duration of veno-arterial extracorporeal life support (VA ECMO) and outcome: an analysis of the Extracorporeal Life Support Organization (ELSO) registry.

Authors:  Myles Smith; Alexander Vukomanovic; Daniel Brodie; Ravi Thiagarajan; Peter Rycus; Hergen Buscher
Journal:  Crit Care       Date:  2017-03-06       Impact factor: 9.097

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.